|
Market Closed -
Euronext Dublin
11:55:00 2026-08-27 EDT
|
5-day change | 1st Jan Change | ||
| 7.000 EUR | 0.00% |
|
0.00% | -9.09% |
| 08-26 | Malin swings to interim profit as finance income rises and costs fall | AN |
| 02-26 | EARNINGS AND TRADING: Connecting Excellence hails record January fees | AN |
| Market Cap | 30.35M 35.35M 28.41M 26.01M 49.01M 3.38B 49.15M 336M 132M 1.7B 133M 130M 5.63B | P/E 2024 * |
-
| P/E 2025 | -8.37x |
|---|---|---|---|---|---|
| Enterprise Value | 17.45M 20.32M 16.33M 14.96M 28.17M 1.94B 28.25M 193M 75.61M 978M 76.3M 74.66M 3.24B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
63.83% | Yield 2024 * |
-
| Yield 2025 | - |
| Current month | -1.41% | ||
| 1 month | -1.41% | ||
| 3 months | -8.50% | ||
| 6 months | -7.89% | ||
| Current year | -9.09% |
| 1 week | 7 |  | 7 |
| 1 month | 6.8 | | 7.15 |
| Current year | 6.8 | | 8.45 |
| 1 year | 6.8 | | 9.3 |
| 3 years | 3.84 | | 10.4 |
| 5 years | 3.59 | | 10.4 |
| 10 years | 1.4 | | 14 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andrea Stafford
DFI | Director of Finance/CFO | 56 | 2022-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
William Daniel
CHM | Chairman | 73 | 2019-08-01 |
| Director/Board Member | 67 | 2018-07-15 | |
Rudy Mareel
BRD | Director/Board Member | 63 | 2018-07-15 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/28/25 | Fiscal year | Chief Executive Officer | 5,746 | 0.1328% | ||
| 4/7/25 | Sell | Director | 11,075 | 0.2560% | ||
| 4/7/25 | Sell | Chief Executive Officer | 17,780 | 0.4110% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | -12.50% | +52.17% | 35.36M | |
| -1.41% | -5.15% | +60.77% | +113.09% | 1,060B | |
| -1.62% | -0.58% | +50.36% | +61.80% | 651B | |
| -2.00% | -1.56% | +23.88% | +74.82% | 465B | |
| -1.17% | -2.10% | +38.61% | +40.46% | 365B | |
| -2.00% | -1.35% | +22.22% | +37.78% | 300B | |
| -0.98% | +0.53% | +2.04% | +12.13% | 258B | |
| -0.63% | +0.95% | +52.05% | +70.67% | 238B | |
| -3.18% | -0.30% | -17.23% | -54.33% | 210B | |
| +0.20% | +3.53% | +30.35% | +92.76% | 184B | |
| Average | -1.21% | -0.60% | +25.06% | +50.14% | 373.04B | |
| Weighted average by Cap. | -1.40% | -2.16% | +38.58% | +66.09% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | - | -6.9M -8.04M -6.46M -5.92M -11.14M -768M -11.17M -76.49M -29.9M -387M -30.18M -29.53M -1.28B |
| Net Debt | -62.1M -72.34M -58.14M -53.24M -100M -6.91B -101M -688M -269M -3.48B -272M -266M -11.52B | -12.9M -15.03M -12.08M -11.06M -20.83M -1.44B -20.89M -143M -55.91M -723M -56.42M -55.2M -2.39B |
Employees
2
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-27 | €7.000 | 0.00% | 0 |
| 26-08-26 | €7.000 | 0.00% | 0 |
| 26-08-25 | €7.000 | 0.00% | 0 |
| 26-08-24 | €7.000 | 0.00% | 2 |
| 26-08-21 | €7.000 | 0.00% | 0 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
7.000EUR
Average target price
15.50EUR
Spread / Average Target
+121.43%
- Stock Market
- Stocks
- MLC Stock
Select your edition
All financial news and data tailored to specific country editions
